CytoSorb receives Health Canada authorisation to treat Covid-19
CytoSorb will be commercially available in North America and 67 other countries across the world to treat Covid-19 patients. Credit: Gerd Altmann / Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more